MULTIPLE PITUITARY HORMONE DEFICIENCY GENETIC FORM

Clinical trials for MULTIPLE PITUITARY HORMONE DEFICIENCY GENETIC FORM explained in plain language.

Never miss a new study

Get alerted when new MULTIPLE PITUITARY HORMONE DEFICIENCY GENETIC FORM trials appear

Sign up with your email to follow new studies for MULTIPLE PITUITARY HORMONE DEFICIENCY GENETIC FORM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Daily injection trial aims to curb uncontrollable hunger in rare brain disorder

Disease control Recruiting now

This study is testing whether a daily injection called setmelanotide can help people aged 4 and older with a rare form of obesity caused by brain injury (hypothalamic obesity). Participants will receive either the real drug or a placebo for 26 weeks to see if it safely reduces bo…

Matched conditions: MULTIPLE PITUITARY HORMONE DEFICIENCY GENETIC FORM

Phase: PHASE3 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

MULTIPLE PITUITARY HORMONE DEFICIENCY GENETIC FORM

Get alerted when new MULTIPLE PITUITARY HORMONE DEFICIENCY GENETIC FORM trials appear

Daily injection trial aims to curb uncontrollable hunger in rare brain disorder